Alembic Standalone September 2020 Net Sales at Rs 16.49 crore, down 30.13% Y-o-Y

Alembic Consolidated September 2020 Net Sales at Rs 16.76 crore, down 29.13% Y-o-Y

Alembic Consolidated June 2020 Net Sales at Rs 13.39 crore, down 48.56% Y-o-Y

Alembic Standalone March 2020 Net Sales at Rs 11.36 crore, down 55.13% Y-o-Y

Alembic Consolidated March 2020 Net Sales at Rs 11.48 crore, down 54.66% Y-o-Y

Alembic Consolidated December 2019 Net Sales at Rs 12.76 crore, down 47.51% Y-o-Y

Alembic Consolidated September 2019 Net Sales at Rs 23.65 crore, down 29.53% Y-o-Y

Alembic Consolidated June 2019 Net Sales at Rs 26.03 crore, down 41.53% Y-o-Y

Alembic Standalone June 2019 Net Sales at Rs 26.03 crore, down 41.53% Y-o-Y

Alembic Consolidated March 2019 Net Sales at Rs 25.32 crore, down 23.76% Y-o-Y

Alembic Standalone March 2019 Net Sales at Rs 25.32 crore, down 23.76% Y-o-Y

Regulatory barriers make this phosgene producer a worthy pick

Alembic Standalone December 2018 Net Sales at Rs 24.31 crore, down 18.78% Y-o-Y

Alembic rejects small shareholders' request for seat on Board

The Alembic board on Friday said it has rejected the request by a section of small shareholders led Unifi Capital to have their representative on the board citing conflict of interests and misuse of provision under Section 151 of the Companies Act.

Minority investors seek seat on Alembic board, analysts say move unprecedented

The regulations under the Companies Act, 2013 allow a small shareholder director on the board with the specific intent of having the interest of small shareholders represented in the decisions made by the board.

Stocks in the news: Bharti Airtel, Dena Bank, Vijaya Bank, Arcotech, Jubilant Life

Bharti Airtel | Dena Bank | Titagarh Wagons | Jubilant Life | Kotak Mahindra Bank | Future Enterprise | Cholamandalam Investment | Vijaya Bank and Arcotech are stocks, which are in news today.

Bull's Eye: Buy Sun Pharma, Pidilite, Alembic, SRF; Sell CESC

Jay Thakkar of Anand Rathi Securities is of the view that one may buy Alembic with a target of Rs 48.70.

Stocks in news: Axis, Infosys, Mindtree, Ruchi Soya, Kalpataru

Axis Bank | Infosys | Mindtree | Tata Steel | Canara Bank | GMR Infrastructure | Orient Green Power | Havells India | TVS Motor | Sterlite Technologies | Kalpataru Power and Ruchi Soya are stocks, which are in the news today.

Bull's Eye: Buy Alembic, NMDC, PC Jewellers; sell HDIL

Sumeet Jain of Destimoney Securities is of the view that one may buy Alembic with a target of Rs 42.80.

Alembic, Cadila & Lupin keep pharma cos in high spirits

An establishment inspection report for Alembic‘s Karakhadi API plant from the regulator is a big positive as API is one of the main drivers for the company, says Sarabjit Kaur Nangra of Angel Broking.

Bull's Eye: Buy CESC, Vijaya Bank, Bharti Infratel, ACC

Krish Subramanyam of Altamount Capital advises buying Alembic with a target of Rs 40.

Stocks in news: Axis Bank, Bharti Infratel, Raymond, Rallis

Axis Bank | Bharti Infratel | Raymond | Rallis India | IDFC Bank | Syngene | Snowman Logistics | Alembic | Swaraj Engines | Agro Tech Foods and Gujarat Narmada Valley are stocks, which are in the news today.

Bull's Eye: Buy Voltas, MCX India, Biocon; sell Hexaware

Manish Sharma of derivativetradingresearch is of the view that one may buy Voltas with a target of Rs 310.

Top buzzing midcap stocks to trade on April 20

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Hindalco, Tata Steel, JK Tyre, MRF, CEAT, DCB Bank, Dwarikesh Sugar, Triveni Engg, Balrampur Chini, HDFC, Alembic and CRISIL.

Indian cos get USFDA nod for 14 first-time generic drugs in 2015

Major domestic firms such as Sun Pharma, Lupin, Glenmark, Aurobindo, Alembic and Hetero Labs figure in the list of first-time generic drug approvals released by the FDA's Office of Generic Drugs.